Guidance
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm - update 15 March 2022
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm
Authors
Languages
- English
Publication year
2021
Type
Categories
Diseases
Countries
Organisations
